Meglumine antimoniate
Pharmaceutical forms
Injection
Country lists
ATC N/A
Composition 30%, equivalent to approximately 8.1% antimony (pentavalent) in 5-ml ampoule
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.5.2. Antileishmaniasis medicines
  • No observations
Solution for IV infusion injection
Country lists
ATC N/A
Composition 85 mg/ml in ampoule
Observations for this pharmaceutical form can be found on the lists:
PAHO Strategic Fund Medicine List
2.7.1. Antileishmaniasis medicines
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru
6.5.2 Anti-Leishmaniasis
  • No observations
Injection
Country lists
ATC N/A
Composition 1.5g/5ml
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Colombia
04. Leishmaniasics
  • No observations
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Injection
Country lists
ATC N/A
Composition 300mg/ml
Observations for this pharmaceutical form can be found on the lists:
Ecuador
Essential Medicines List - Ecuador
  • No observations